CLU and atrial fibrillation: Our current analyses reveal that none of the Apo is very accurate in predicting the onset of AF, but, notably, it shows that plasma concentrations of Apo-J can be used as a sensitive non-invasive short-term biomarker of cryotherapy success (confirming maintenance of sinus rhythm) in patients with AF.